Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 12-2018 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 457,608 | 0 | 304 | 7 | 7 |
Gross Profit | 457,608 | N/A | 304 | 7 | 7 |
Operating Expenses | 129,749 | 0 | 1,919 | 2,206 | 5,917 |
Operating Income | 327,859 | N/A | -1,615 | -2,199 | -5,910 |
Interest Expense | 69,168 | 0 | 0 | 0 | 0 |
Other Income | -79,921 | 0 | 0 | 0 | 0 |
Pre-tax Income | 178,770 | 0 | -1,615 | -2,199 | -5,910 |
Net Income Continuous | 178,770 | N/A | -1,615 | -2,199 | -5,910 |
Minority Interests | 27,057 | N/A | N/A | N/A | N/A |
Net Income | $151,713 | $N/A | $-1,615 | $-2,199 | $-5,910 |
EPS Basic Total Ops | N/A | N/A | -0.04 | -0.08 | -0.22 |
EPS Basic Continuous Ops | N/A | N/A | -0.04 | -0.08 | -0.23 |
EPS Diluted Total Ops | N/A | N/A | -0.04 | -0.08 | -0.22 |
EPS Diluted Continuous Ops | N/A | N/A | -0.04 | -0.08 | -0.23 |
EBITDA(a) | $327,859 | $N/A | $-1,614 | $-2,198 | $-5,909 |